Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 6—June 2010

Dispatch

Variations in Human Herpesvirus Type 8 Seroprevalence in Native Americans, South America

Vanda A.U.F. Souza, Francisco M. Salzano, Maria Luiza Petzl-Erler, Maria Claudia Nascimento, Philippe Mayaud, Jaila Dias Borges, and Claudio S. PannutiComments to Author 
Author affiliations: Universidade de São Paulo, São Paulo, Brazil (V.A.U.F. Souza, C.S. Pannuti, M.C. Nascimento, J.D. Borges); Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil (F.M. Salzano); Universidade Federal do Paraná, Curitiba, Brazil (M.L. Petzl-Erler); London School of Hygiene and Tropical Medicine, London, UK (M.C. Nascimento, P. Mayaud).

Main Article

Table 1

Prevalence of HHV-8 antibodies in Amazonian and non-Amazonian Native American populations, by assay type*

Population, locality†
No. persons tested
No. (%) persons HHV-8 seropositive
By IFA-LANA or IFA-lytic
By IFA-LANA
By IFA-lytic
By IFA-LANA and IFA-lytic
Wai-Wai, Mapuera, Brazil 530 397 (75) 372 (70) 204 (38) 177 (33)
Xikrin, Caeteté, Brazil 30 15 (50) 13 (43) 6 (20) 4 (13)
Gorotire, PI Gorotire, Brazil 30 20 (67) 20 (67) 7 (23) 7 (23)
Kuben-Kran-Kegn, Nilo Peçanha, Brazil 30 25 (83) 25 (83) 4 (13) 4 (13)
Krahó, Cachoeira, Brazil 20 12 (60) 10 (50) 10 (50) 7 (35)
Ayoreo,Tobité, Bolivia 18 5 (28) 5 (28) 2 (11) 2 (11)
Ayoreo, Pozo Verde, Bolivia 17 3 (18) 2 (12) 1 (6) 0 (0)
Ayoreo, M Auxiliadora, Paraguay 20 9 (45) 9 (45) 7 (35) 7 (35)
Kaingang, Ivaí, Brazil 30 0 0 0 0
Kaingang, Rio das Cobras, Brazil 26 0 0 0 0
Guarani, Rio das Cobras, Brazil 29 4 (14) 4 (14) 2 (7) 2 (7)

*HHV-8, human herpesvirus type 8; IFA, immunofluorescence assay; LANA, latency-associated nuclear antigen.
†Listed in a north–south gradient (Figure).

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO